Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections

Annals of Surgery

Volumn 233, Issue 1, 2001, Pages 79-87

  Solomkin, Joseph S ^a,h   Wilson, Samuel E ^b   Christou, Nicholas V ^d   Rotstein, Ori D ^d   Dellinger, E Patchen ^c   Bennion, Robert S ^e,f   Pak, Raphael ^g   Tack, Kenneth ^g  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g PFIZER INC   (United States)

^h UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN PLUS IMIPENEM; CLINAFLOXACIN;

ABDOMINAL INFECTION; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME;

EID: 0035161036     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200101000-00013     Document Type: Article

References (34)

1. Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone
2. The role of Pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis
3. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intraabdonminal infections
4. Antibiotic treatment for surgical peritonitis
5. The bacteriology of intraabdominal infections
6. Lessons from an animal model of intraabdominal sepsis
7. Enterococcal infections in surgical patients: The mystery continues
8. Microbial synergy in experimental intraabdominal abscess
9. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intraabdominal infections
10. Trovafloxacin in the treatment of intraabdominal infections: Results of a double-blind, multicenter comparison with impenem/cilastatin
11. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: Correlation with in vitro susceptibilities
12. Appelbaum PC. Comparative activities of clinafloxacin against gram-positive and -negative bacteria
13. In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers
14. In vitro susceptibility of anaerobes to quinolones in the United States
15. General guidelines for the clinical evaluation of anti-infective drug products
16. Evaluation of new anti-infective drugs for the treatment of intraabdominal infections
17. APACHE II: A severity of disease classification system
18. Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections
19. Imipenem versus tobramycin-antianaerobe antibiotic therapy in intra-abdominal infections
20. Management of intraabdominal infections. The case for intraoperative cultures and comprehensive broad-spectum antibiotic coverage
21. Biapenem versus imipenem/cilastatin in the treatment of complicated intraabdominal infections
22. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intraabdominal infections
23. Pathogenicity of the enterococcus in surgical infections
24. Piperacillin-tazobactam versus imipenem/cilastatin for treatment of intraabdominal infections
25. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections
26. Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery
27. Meropenem versus imipenem/cilastatin in intraabdominal infections requiring surgery
28. CT features of intraabdominal abscesses: Prediction of successful percutaneous drainage
29. Improved treatment of intraabdominal abscess. A result of improved localization, drainage, and patient care, not technique
30. Perforated and gangrenous appendicitis: All analysis of antibiotic failures
31. Matched case-control study of adjusted versus nonadjusted gentamicin dosing in perforated and gangrenous appendicitis
32. Prognosis in generalized peritonitis
33. Prospective evaluation of prognostic scoring systems in peritonitis
34. Definition of the role of enterococcus in intraabdominal infection: Analysis of a prospective randomized trial